Decisiones oficiales de clasificación arancelaria publicadas por la Comisión Europea
5 Reglamentos
Preparación de simeticona
Producto presentado en cápsulas de gelatina, que contiene principalmente simeticona (sustancia antiespumante), complementada con excipientes, colorantes y aditivos alimentarios, destinado al consumo humano para aliviar dolores estomacales, hinchazón y flatulencias. Utilizado en dosis controladas tras las comidas, este producto se clasifica como preparación con finalidad fisiológica o de confort digestivo, generalmente como preparaciones alimentarias de uso dietético o, si existe una alegación terapéutica o registro, como medicamento (sujeto a legislación nacional específica). Debe cumplir con la normativa sobre complementos alimenticios o medicamentos según su puesta en el mercado, con conformidad a las directivas de la UE para sustancias, aditivos y seguridad.
8 jun 2016
Complemento alimenticio en comprimidos
Se trata de un complemento alimenticio presentado en comprimidos para venta minorista, cada comprimido (900 mg) que contiene principalmente ácido alfa-lipoico (300 mg) y calcio (88,5 mg en forma de fosfato de calcio dibásico), complementados con excipientes (celulosa, etilcelulosa, dióxido de silicio, estearato de magnesio). Destinado al consumo humano con una posología de un comprimido por día, está sujeto a la normativa europea sobre complementos alimenticios (seguridad, composición, etiquetado).
28 nov 2013
Eyecare product (ophthalmic solution) composed of the active ingredient: poly(vinyl alcohol) (lubricant) 1,4 %, and of the other ingredients: sodium chloride (tonicity agent); sodium dihydrogenphosphate (buffering agent); disodium hydrogenphosphate (buffering agent); benzalkonium chloride (preservative); disodium edetate (chelating agent); hydrochloric acid (pH- adjuster); sodium hydroxide (pH- adjuster); and purified water, q.s. to 100 % (vehicle). The product is put up for retail sale (15ml-dr
Classification is determined by the provisions of General Rules 1 and 6 for the interpretation of the Combined Nomenclature and by the wording of CN codes 3004 and 3004 90 00. The product is prepared and put up for therapeutic use as a lubricant and artificial tear in dry-eye and other ocular irritation syndromes. The preparation is not for use as a contact lens or artificial eye solution of heading 3307. Documented CN 2026 code: 30049000.
28 jul 2004
Item 1: Amber syrup, intended to correct iron- deficiency, put up in 125-ml bottles. Its composition per 100 g is: 4,13 g sodium feredetate (a soluble ferric compound of crystallised sodium ethylenediamine tetra-acetate), 24 g sorbitol, 13 g glycerine, 0,1 g citric acid, 0,09 g ethyl alcohol 95°, 0,01 g flavouring agent, 0,01 g propyl parahydroxybenzoate, 0,08 g methyl parahydroxybenzoate, and quant.suff. water.
Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the Combined Nomenclature and by the wording of CN codes 3004 and 3004 90 00. This product must be considered as a medicament because of its composition and its use for therapeutic purposes. Documented CN 2026 code: 30049000.
4 dic 1995
Item 6: Injectable preparation, sterile, pyrogen- free, consisting of purified collagen dispersed in a phosphate-buffered physiological saline solution, whether or not containing lidocaine (INN), put up for retail sale
Classficiation is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 3004 and 3004 90 00. This product is used in the treatment of atrophy due to disease, trauma or other disorders of the conjunctive tissue Whereas, in order to ensure uniform Documented CN 2026 code: 30049000.
7 jul 1989